Skip to main content

Point72 Asset Management, L.P.

Position in ELVN — Enliven Therapeutics, Inc.

CIK 1603466 STAMFORD, CT

Position in ELVN

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
-$23,170,855 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2023
6 quarters on record

Common Shares in ELVN Over Time

Shares Held

Position Value (USD)

Derivatives in ELVN

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$1,552,320
PutShares
39,600

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in ELVN

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,552,320 39,600
2025-12-31 $23,170,855 1,504,601
2025-09-30 $21,297,192 1,040,410
2025-06-30 $27,142,744 1,353,078
2025-03-31 $2,753,586 139,918
2023-03-31 $16,337 746